Aditxt, Inc.ADTXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank71
3Y CAGR-50.3%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-50.3%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202453.88%
2023-2.66%
202244.12%
2021437.65%
2020434.63%
2019-66.58%
20180.00%
20170.00%